• AAPL 168.6389
  • TSLA 160.03
  • AMZN 176.48
  • MSFT 407.14
  • INTC 34.635
  • EURUSD 1.0692
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. IMTX.NASDAQ

Immatics NV (IMTX NASDAQ) stock market data APIs

$10.25 -0.17(-1.6%) as of April 23, 2024

Immatics NV Financial Data Overview

10.42
10.25
-
10.6
10.25
6.46-13.16
1 073 M
103 M
53 997 K
-0.3
0.676
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'IMTX',
Type: 'Common Stock',
Name: 'Immatics NV',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
ISIN: 'NL0015285941',
CUSIP: NULL,
CIK: '1809196',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-07-02',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Immatics NV Fundamental Data is available in our Financial Data APIs

  • Net Revenue 53 997 K
  • EBITDA -98 352 000
  • Earnings Per Share -1.28
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Immatics NV Earnings via APIs

  • Latest Release 2024-03-21
  • EPS/Forecast -0.32

Get Immatics NV End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Immatics NV latest news via APIs

15 Small-Cap Stocks with High Potential

In this article, we will take a look at the 15 small-cap stocks with high potential. To skip our analysis of the latest trends, and market activity, you can go directly to see the 5 Small-Cap Stocks w...

Immatics Announces Pricing of $175 Million Public Offering

https://immatics.com/ Houston, Texas and Tuebingen, Germany, January 17, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and ...
Do you have any questions?
support@eodhistoricaldata.com